Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Return on Sales (2022 - 2025)

Neuraxis (NRXS) has disclosed Return on Sales for 4 consecutive years, with 1.8% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 12.0% to 1.8% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.21% through Dec 2025, up 51.0% year-over-year, with the annual reading at 2.21% for FY2025, 67.0% up from the prior year.
  • Return on Sales hit 1.8% in Q4 2025 for Neuraxis, up from 2.62% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.03% in Q2 2022 to a low of 6.33% in Q3 2023.
  • Historically, Return on Sales has averaged 2.52% across 4 years, with a median of 2.11% in 2022.
  • Biggest five-year swings in Return on Sales: crashed -422bps in 2023 and later skyrocketed 375bps in 2024.
  • Year by year, Return on Sales stood at 1.87% in 2022, then plummeted by -64bps to 3.06% in 2023, then surged by 37bps to 1.93% in 2024, then increased by 6bps to 1.8% in 2025.
  • Business Quant data shows Return on Sales for NRXS at 1.8% in Q4 2025, 2.62% in Q3 2025, and 1.94% in Q2 2025.